Showing results (1581-1590 of 2,066) with videos related to

Sort By:
Pageof 207
Evolution, Medicine, and Public Health|September 5, 2024
Germline mutation rate predicts cancer mortality across 37 vertebrate speciesStefania E Kapsetaki, Zachary T Compton, Walker Mellon, et al.
Journal of Clinical Microbiology|January 2, 2025
Validation of a simplified HPV genotyping assay designed for cervical screening in low-resource settingsKanan T Desai, Kayode O Ajenifuja, Clement A Adepiti, et al.
International Journal of Cancer|August 9, 2011
Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatmentAimée R Kreimer, Mark Schiffman, Rolando Herrero, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 20, 2004
Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa RicaRaphael P Viscidi, Mark Schiffman, Allan Hildesheim, et al.
Journal of the National Cancer Institute|October 15, 2010
Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infectionsMahboobeh Safaeian, Carolina Porras, Mark Schiffman, et al.
Obstetrics and Gynecology|November 9, 2016
Similar Risk Patterns After Cervical Screening in Two Large U.S. Populations: Implications for Clinical GuidelinesJulia C Gage, William C Hunt, Mark Schiffman, et al.
BMC Cancer|October 21, 2018
Untargeted lipidomic features associated with colorectal cancer in a prospective cohortKelsi Perttula, Courtney Schiffman, William M B Edmands, et al.
International Journal of Cancer|March 13, 2019
Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotestingRebecca Landy, Mark Schiffman, Peter D Sasieni, et al.
Pageof 207